Will I lose weight on 5mg Mounjaro?

What SURMOUNT-1 actually shows about tirzepatide at lower doses

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity to tirzepatide at 5mg, 10mg or 15mg, or placebo, over 72 weeks. All participants received lifestyle support alongside treatment. The results were dose-dependent: the 5mg group lost an average of around 15% of body weight, the 10mg group around 19.5%, and the 15mg group around 20–21%. Those figures matter. A 15% average at 5mg is clinically significant. It is not as dramatic as the headline 15mg number reported most often, but it is meaningfully more than lifestyle changes typically produce alone, and well above the 3.2% average in the placebo group.

What the trial does not tell you is what you personally will lose. Averages hide a wide spread: some people on 5mg lose more than the average, some less. If you want a fuller picture of whether you can expect to lose weight on 5mg of Mounjaro, including what the evidence says about individual variation, that page goes into the detail behind the trial averages. You can read more about what to expect on the 5mg pen, including how this phase of treatment typically feels day to day.

Is 5mg a stepping stone or can it be your maintenance dose?

Tirzepatide's licensed schedule starts at 2.5mg for the first four weeks, a dose whose job is to let your body adjust, not to drive weight loss. After that, 5mg is the first dose at which most people notice a real change in appetite. The 2.5mg pen is specifically a tolerability step; 5mg is where the clinical work begins.

Some people stay on 5mg as their long-term maintenance dose because they tolerate it well, are losing at a rate that suits them, and have no clinical reason to go higher. Others find their weight loss plateaus before they reach their goal, and a prescriber may recommend moving to 7.5mg. That decision is based on evidence: how much weight you have lost, how you are tolerating the current dose, and whether progress is continuing. Whether you lose more weight by staying at 5mg or moving up depends on your individual clinical picture, not a formula. The NICE guidance on tirzepatide (TA1026) recommends reviewing continuation if less than 5% of body weight has been lost after six months at the highest tolerated dose, a threshold that underlines how seriously ongoing progress is tracked.

What influences how much weight you lose at 5mg

The medicine reduces appetite and slows gastric emptying, but it works alongside what you eat and how active you are, not instead of those things. People who pair 5mg Mounjaro with a modest calorie reduction and regular activity tend to lose more than those who do not. Protein intake matters too: eating enough protein while in a calorie deficit helps preserve muscle, which keeps your metabolism working as you lose weight. Your prescriber and the patient information leaflet will outline the lifestyle context that supports treatment.

Side effects also play a role in early weeks. Nausea, tiredness and loose stools are common as the body adjusts; severe nausea can temporarily reduce food and fluid intake beyond what is comfortable, which may distort early readings on the scale. These effects tend to settle. If they do not, or if they are affecting your ability to stay hydrated, that is a conversation to have with your prescriber rather than a reason to stop without guidance. Keeping your pen in the fridge door and your routine consistent (same day, same time each week) makes the treatment easier to sustain.

If you are considering what 5mg costs as part of a longer treatment plan, the Mounjaro pricing page gives an honest overview of what private treatment involves. The 7.5mg dose page covers what changes when the dose increases, if that is the direction your prescriber recommends.

When to speak to a prescriber about your progress at 5mg

If you have been on 5mg for four or more weeks and feel your weight has stalled, or if side effects are making the current dose hard to manage, those are both valid reasons to seek a clinical review. A prescriber will look at the whole picture: how much you have lost so far, how the dose is sitting, whether your BMI and any related conditions are improving. They may recommend staying at 5mg for longer, adjusting lifestyle support, or moving to the next dose.

What they will not do is increase the dose simply because the number on the scale has not moved for a fortnight. Weight loss is not linear. A short plateau in the first few months does not mean treatment is failing; it often means the body is recalibrating. Patience at each dose step is clinically reasonable. Our prescribers at nume review every repeat order before it is dispensed, and follow-up questions between orders are handled by our aftercare team seven days a week. If you have questions about whether 5mg is the right dose for your situation, speaking to our prescribers is the straightforward next step.